Core Insights - TeleVox has launched Insights360, a cloud-based analytics solution designed to enhance patient call experiences by analyzing every aspect from dial to disconnect [1][3] - The technology records calls within the telecom network and generates patient-centered data, focusing on the customer's perspective rather than the agent's [3][4] Product Features - Insights360 provides customized analytics to identify specific challenges in healthcare organizations, enabling smarter self-service and reduced operational costs [4] - The solution offers actionable insights, such as identifying network connectivity issues, reasons for agent transfers, and analyzing repeat calls for better resolution [4] Industry Context - TeleVox serves over 7,000 healthcare organizations, integrating its patient relationship management platform with electronic health records to facilitate two-way interactions [6] - The company has been in operation for 30 years, focusing on improving healthcare communication and reducing the operational burden on staff [6][7] Upcoming Events - TeleVox will showcase Insights360 at the Becker's Healthcare Annual Meeting from April 28 to May 1 in Chicago, where attendees can participate in live demos and workshops [5]

Core Insights - OneMedNet has formed a strategic partnership with Protege to provide real-time access to multimodal patient data for AI developers and researchers, enhancing the development of AI solutions in healthcare [1][2][5] - The collaboration aims to improve the precision and relevance of AI models, ultimately enhancing patient outcomes and driving medical breakthroughs [2][5] - OneMedNet's data includes deep clinical information beyond traditional electronic health records, such as medical imaging and various diagnostic modalities, ensuring a comprehensive dataset for AI applications [3][7] Company Overview - OneMedNet is a leader in AI-powered Real-World Data, utilizing over 1,400 healthcare sites through its iRWD™ platform to provide valuable insights for drugmakers and medical device innovators [7] - The company focuses on delivering precision insights across various medical fields, including rare diseases, oncology, and cardiology, aiming to redefine patient care [7] - Protege serves as a platform for AI training data, facilitating compliant data exchange and supporting the creation of thoughtful AI solutions [6]

Core Insights - Aclarion, Inc. is a healthcare technology company focused on chronic low back pain, utilizing biomarkers and proprietary AI algorithms to assist physicians in identifying pain sources [1][4] - The company will present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025, highlighting recent initiatives aimed at enhancing value [2][1] - Aclarion has released an updated investor presentation available on its website [3] Company Overview - Aclarion leverages Magnetic Resonance Spectroscopy (MRS) and proprietary signal processing techniques to optimize clinical treatments for chronic low back pain [4] - The company's primary product, Nociscan, is a SaaS platform designed to noninvasively differentiate between painful and nonpainful discs in the lumbar spine [4] - Nociscan utilizes cloud technology to analyze MRS data from MRI machines, extracting chemical biomarkers associated with disc pain to provide insights for treatment optimization [4]

Core Viewpoint - Clover Health Investments, Corp. announces that Lee A. Shapiro will not seek reelection to the Board of Directors due to new responsibilities as Chairman of the American Heart Association, with his term ending on June 10, 2025 [1][2]. Company Leadership Changes - Lee A. Shapiro has served on Clover Health's Board for four years and has contributed significantly to the company's mission [2]. - Andrew Toy, CEO of Clover Health, expresses gratitude for Shapiro's leadership and insights during his tenure [2]. - Vivek Garipalli, Executive Chairperson and founder, acknowledges Shapiro's unique contributions and announces that Thomas L. Tran will take over as Chairman of the Audit Committee and Nominating and Corporate Governance Committee effective June 10, 2025 [2][3]. Company Overview - Clover Health is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors [4]. - The company utilizes its software platform, Clover Assistant, to aggregate patient data and improve health outcomes through early identification and management of chronic diseases [4]. - Clover Health offers PPO and HMO Medicare Advantage plans and extends its technology benefits to a broader audience through its subsidiary, Counterpart Health [4].

Core Insights - Axxess and Texas Capital have announced a product integration aimed at speeding up payment reconciliation for home health and hospice providers, enhancing operational efficiency through automation [1][2][3] Company Overview - Axxess is a leading global technology platform for healthcare at home, serving over 9,000 organizations and more than 7 million patients worldwide, recognized for its secure and compliant software solutions [4] - Texas Capital Bancshares, Inc. is a full-service financial services firm that provides customized solutions across various sectors, including commercial and consumer banking, investment banking, and wealth management [5] Product Integration Details - The integration combines Texas Capital's RevNow product with Axxess RCM, allowing providers to automate payment matching, reducing the reconciliation time from weeks to just 24 hours [2][3] - RevNow processed 115 million claims nationwide in 2024, showcasing its significant impact in the healthcare space [3] Value Proposition - The partnership is expected to save providers substantial time and costs by streamlining operations through automation and artificial intelligence, allowing them to focus on core business activities [2][3]

Core Insights - Aclarion, Inc. has published a peer-reviewed article demonstrating the cost-effectiveness of its Nociscan solution compared to provocative discography for identifying chronic low back pain surgery candidates [1][2] - The study indicates that Nociscan saves approximately $1,712 per patient and improves surgical success rates by 10% [5] Company Overview - Aclarion is a healthcare technology company focused on chronic low back pain, utilizing Magnetic Resonance Spectroscopy (MRS) and proprietary algorithms to help physicians differentiate between painful and non-painful discs [4] - Nociscan is the first evidence-supported SaaS platform designed to noninvasively assist in diagnosing disc-related pain [4] Industry Context - Chronic low back pain affects around 266 million people globally, highlighting the significant healthcare challenge it presents [2] - The publication in ClinicoEconomics and Outcomes Research emphasizes the need for more evidence on clinical and economic improvements in healthcare diagnostics [1]

RESTON, Va., April 18, 2025 /PRNewswire/ -- Leidos (NYSE: LDOS) is committing $10 million to accelerate the use of artificial intelligence for detecting and managing diseases, in collaboration with the University of Pittsburgh's Computational Pathology and AI Center of Excellence (CPACE).The initial focus of the five-year collaboration will be developing AI-powered tools for quicker detection of diseases, such as heart disease and cancer, reducing diagnostic turnaround times, and enabling earlier, more effe ...

Core Insights - Nextech is launching a new med spa aesthetic platform and previewing a new CRM technology at The Medical Spa Show in Las Vegas, aimed at enhancing client care and business management for specialty providers [1][4] - The new Nextech MedSpa platform is designed to meet clinical and regulatory requirements, allowing providers to deliver exceptional client care while efficiently managing their practices [2][3] - The importance of maintaining patient relationships in the context of healthcare consumerism is emphasized, with a tailored CRM expected to improve care outcomes and practice growth [3] Company Overview - Nextech has been providing innovative healthcare technology solutions since 1997, serving over 16,000 physicians and 60,000 office staff across various clinical specialties including dermatology, med spa, ophthalmology, orthopedics, and plastic surgery [5] - The company focuses on driving efficiency, fueling growth, and enhancing the patient care experience through its comprehensive technology solutions [5]

Company Overview - Aclarion, Inc. is a healthcare technology company focused on leveraging biomarkers and proprietary augmented intelligence algorithms to assist physicians in identifying the location of chronic low back pain [1][3] - The company is addressing the chronic low back pain market with its product Nociscan, which is the first evidence-supported SaaS platform designed to noninvasively help physicians distinguish between painful and non-painful discs in the lumbar spine [3] Product Details - Nociscan utilizes Magnetic Resonance Spectroscopy (MRS) and proprietary signal processing techniques to optimize clinical treatments [3] - The platform receives MRS data from MRI machines and processes it in the cloud to extract and quantify chemical biomarkers associated with disc pain [3] - Nociscan provides critical insights into the location of a patient's low back pain, enabling physicians to optimize treatment strategies [3] Upcoming Events - Aclarion will present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025, at 12:30 PM ET, hosted by CEO Brent Ness [1][2] - The presentation will be accessible via a live webcast, and 1x1 investor meetings can be scheduled at the conference venue [2]

Core Insights - Clover Health Investments, Corp. will report its first quarter 2025 financial results on May 6, 2025, after market close, followed by a conference call at 5:00 p.m. Eastern Time to discuss the results [1][3] Company Overview - Clover Health is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors who have historically faced challenges in accessing affordable healthcare [2] - The company's strategy is driven by its software platform, Clover Assistant, which aggregates patient data to support clinical decision-making and improve health outcomes, particularly in managing chronic diseases [2] - Clover Health offers PPO and HMO Medicare Advantage plans across several states, emphasizing its flagship wide-network, high-choice PPO plans [2] - Through its subsidiary, Counterpart Health, Clover Health extends its data-driven technology to a broader audience, aiming to enhance patient outcomes and reduce healthcare costs nationwide [2] - The company has published data showcasing the positive impact of its technology on medication adherence and the early identification and management of diabetes and chronic kidney disease [2]